<DOC>
	<DOCNO>NCT02131558</DOCNO>
	<brief_summary>Patients endometrial cancer plan robotic laparoscopic hysterectomy full bilateral pelvic para-aortic lymphadenectomy receive injection fluorescent dye , Indocyanine green ( ICG ) . ICG spread lymphatic system , visualize use near-infrared ( NIR ) imagers . Upon visualization path ICG , sentinel lymph node ( SLNs ) , first nod receive drainage primary tumor , identify . SLNs surgically remove provided Pathology evaluation . Non-sentinel node also surgically remove , consistent routine medical care patient , give Pathology evaluation . A positive SLN may accurate identifier extra-uterine spread disease , provide information extent surgical node removal necessary .</brief_summary>
	<brief_title>Indocyanine Green Near-infrared Fluorescence Imaging Detect Sentinel Lymph Nodes Patients With Endometrial Cancer</brief_title>
	<detailed_description />
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>Adult woman patient ( &gt; 18 year age &lt; 90 year age ) Research authorization ( consent ) Preoperative diagnosis clinical Stage 1 endometrial cancer Preoperative indication grade 3 tumor , and/or tumor size great 2 cm size Scheduled consent undergo robotic hysterectomy surgical staging , include bilateral pelvic paraaortic lymphadenectomy Severe coagulopathy severe thrombocytopenia Severe anemia Severe cardiopulmonary comorbidities demand minimization operative time History liver disease Iodide allergy Emergent operation Additional surgical risk determine surgery discretion attend Impaired capacity make inform medical decision</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Endometrial cancer</keyword>
	<keyword>Sentinel lymph node</keyword>
	<keyword>Indocyanine green</keyword>
	<keyword>Near infrared imaging</keyword>
</DOC>